Ekso Bionics to Present at International CES 2015
GlobeNewswire - Tue Dec 23, 6:00AM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that their robotic technology expertise will be featured on two separate panels at the International Consumer Electronics Show (CES).
Can Robot Exoskeletons Overcome Price Barriers?
ARK Investment Management - at Seeking Alpha - Wed Dec 17, 12:49PM CST
Though robot exoskeleton developer ReWalk Robotics (NASDAQ: RWLK ) completed a $150 million initial public offering (IPO) in September, patient adoption of the company’s technology will be limited until the unit price decreases....
RWLK: 21.66 (+0.11)
Market Maker Surveillance Report. JRJC, ECSL, TLOG, WLDN, HGSH, EKSO, Losing Stocks With Lowest Price Friction For Tuesday, December 16th 2014
M2 - Wed Dec 17, 2:18AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 5122 companies with "abnormal" market making, 2762 companies with positive Friction Factors and 4010 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. China Finance Online Co Ltd (NASDAQ:JRJC), ECARE SOLUTIONS INC (OTC:ECSL), TRANSFORM LOGIC CORP (NASDAQ:TLOG), Willdan Group Inc (NASDAQ:WLDN), China Hgs Real Estate Inc (NASDAQ:HGSH), (OTC:EKSO). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
JRJC: 5.81 (-0.11), HGSH: 4.60 (-0.06), TLOG: 4.45 (-0.09), WLDN: 12.77 (+0.45)
Hocoma, Ekso Bionics and AlterG Top TechNavio's List of Leading Rehab Robotics Companies
Business Wire - Thu Dec 11, 11:45AM CST
TechNavio, a tech-focused research firm has published a list of the top 15 companies in the Global Rehabilitation Robotics Market.
Ekso Bionics Holdings names Stanley Stern as independent director
M2 - Wed Dec 10, 5:57AM CST
Robotic exoskeleton company Ekso Bionics Holdings (OTCBB:EKSO) revealed on Tuesday the addition of Stanley Stern as its independent director.
Stanley Stern Joins Ekso Bionics Board of Directors
GlobeNewswire - Tue Dec 09, 3:53PM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), announced the appointment of Stanley Stern as an independent director of the firm, effective immediately. Mr. Stern's appointment expands the Board to six directors.
ReWalk Longs Could Have A Long Road Ahead
Dallas Salazar - at Seeking Alpha - Mon Dec 08, 12:00PM CST
RWLK: 21.66 (+0.11)
Ekso Bionics to Host Technology & Development Day
GlobeNewswire - Thu Dec 04, 3:40PM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that they will be hosting a demonstration featuring their patented industrial and medical exoskeleton technology on Tuesday, December 9 from 7:30-10:30 am Eastern time in New York.
Soldier Socks Donates Robotic Exoskeleton to Bronx VA Medical Center at First Annual Soldier Socks Awards Ceremony
GlobeNewswire - Wed Dec 03, 4:41PM CST
SoldierSocks, a non-profit organization focused on helping veterans, is hosting their first annual awards ceremony at The Union League of New York. This year's program includes a donation of an Ekso GT(TM) (OTCQB:EKSO) robotic exoskeleton to the James J. Peters VA Medical Center in the Bronx, NY. In addition, SoldierSocks will be awarding the 2014 Commitment to Service Award to Martha MacCallum, Co-Anchor of America's Newsroom and presenting the 2014 Corporate Leadership Award to United Rentals, Inc.
URI: 104.84 (+0.16)
Ekso Bionics to Submit 510(k) Notification in December
GlobeNewswire - Tue Dec 02, 7:27AM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that Ekso Bionics recently met with FDA to discuss a change to the regulatory status of the Ekso robotic exoskeleton and other similar medical devices. Based on these discussions, the company made the decision to submit a 510(k) notification for the product in December. Ekso Bionics has been allowed to continue marketing the product while the 510(k) filing is under review. FDA is requiring Ekso Bionics to notify their customers of these changes in the form of a letter, which customers can expect to receive this week. Ekso Bionics is committed to full compliance with FDA's medical device regulations and is working with FDA to fully address the regulatory issues stemming from the recent change in classification for powered exoskeletons.
Super Stock Profits OTC Daily Trading News: Ekso Bionics Holdings, Inc. Sino Argo Food, Inc. HC2 Holdings, Inc. Natural Health Trends Corp, Fannie Mae.
PR Newswire Europe - Wed Nov 26, 10:12AM CST
LONDON, October 7, 2014 /PRNewswire/ --
Medical Advances & Technology Challenges Fueling Volume Into Small Cap Stocks
ACCESSWIRE - Tue Nov 25, 7:01AM CST
Boca Raton, FL / ACCESSWIRE / November 25, 2014 / 2015 is just around the corner and yet futuristic views are not so far away. Medical technology moves at great strides forward while the Digital Communications continue to present challenges and opportunities.
Ekso warrant holders cash in
Seeking Alpha - at Seeking Alpha - Mon Nov 24, 11:28AM CST
Ekso Bionics Completes Offer to Amend and Exercise Its Warrants - Brings Total Raised in 2014 to Over $53 Million
GlobeNewswire - Mon Nov 24, 8:14AM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that warrant holders have elected to exercise 22.8 million of their $2.00 warrants at a reduced exercise price of $1.00 per share, providing $22.8 million in gross proceeds to Ekso Bionics. Additionally, Ekso Bionics has received approval of a majority of the Company's warrant holders to remove the price-based anti-dilution provisions from the outstanding warrants, simplifying the Company's path to a future up-listing onto a primary exchange.
Ekso Bionics to Present at the Canaccord Genuity Medical Technologies and Device Forum 2014
GlobeNewswire - Thu Nov 13, 6:00AM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that Nathan Harding, chief executive officer and co-founder, will present at the Canaccord Genuity Medical Technologies and Device Forum 2014 on Thursday, November 20 at 3:30pm Eastern time in New York.
Ekso Bionics Holdings EPS of -$0.04
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 4:59PM CST
Ekso Bionics Reports Third Quarter 2014 Financial Results
GlobeNewswire - Mon Nov 10, 4:22PM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today reported financial results for the quarter ended September 30, 2014, as well as recent highlights.
Ekso Bionics(TM) to Host Third Quarter 2014 Conference Call on Tuesday, November 11, 2014
GlobeNewswire - Thu Nov 06, 6:08AM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company today announced that it will host a conference call and audio webcast to discuss quarterly results for its third quarter and provide a general business update on Tuesday, November 11, 2014 at 4:30pm ET.
Ekso Bionics Licences Intellectual Property to Ottobock
GlobeNewswire - Mon Nov 03, 6:02AM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today they have formalized a licensing agreement providing intellectual property to Ottobock, the global leader in prosthetics and an innovator in the field of neuro-rehabilitation. Working together, Ekso Bionics and Ottobock will be able to accelerate the pace of innovation in the field of prosthetics to provide the next generation of assistive mobility options. Ekso Bionics will receive a combination of license and royalty payments in return for licensing two of its patents to Ottobock.
Ekso Bionics(TM) Receives Its First NIH Grant
GlobeNewswire - Tue Oct 28, 6:15AM CDT
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that it has been awarded a P20 Exploratory Grant from the National Institutes of Health (NIH) to continue the development of an exoskeleton prototype for children. This work will be done in collaboration with the pediatric rehabilitation department at the UCSF Benioff Children's Hospital Oakland and will consist of Ekso Bionics developing a pediatric version of its Ekso GT(TM) robotic exoskeleton. Working with UCSF Benioff Children's Hospital Oakland allows for the effective integration of advanced robotics into a world-class pediatric rehabilitative practice.